Search results for " Schizophrenia."

showing 10 items of 75 documents

Genes, dopamine and cortical signal-to-noise ratio in schizophrenia.

2004

A large body of phenomenological evidence implicates abnormal connectivity of brain macrocircuitry and microcircuitry in schizophrenia. Recent discoveries of susceptibility genes for schizophrenia have zeroed in on the synaptic signaling machinery of cortical microcircuits as fundamental to disease causation and have militated for further revision of the role of dopamine in this illness. Dopamine, long implicated in psychosis and in antipsychotic drug effects, is crucial in optimizing signal-to-noise ratio of local cortical microcircuits. This action of dopamine is achieved principally by D1- and D2-receptor-mediated effects on pyramidal and local circuit neurons, which mediate neuronal exc…

Cerebral CortexPsychosisGeneral NeuroscienceDopamineCentral nervous systemGlutamate receptormedicine.diseasechemistry.chemical_compoundmedicine.anatomical_structurechemistryDopamineSchizophreniamedicineSchizophreniaHumansSynaptic signalingNerve NetPsychologyNeurotransmitterNeuroscienceDopamine hypothesis of schizophreniamedicine.drugTrends in neurosciences
researchProduct

Retraction notice to “Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and…

2012

DrugNoticemedia_common.quotation_subjectPharmacologyFirst episode schizophreniaPsychiatry and Mental healthCerebrospinal fluidMonoamine neurotransmitterAnesthesiaDopamine receptor D2medicineQuetiapineIn patientPsychologyBiological Psychiatrymedicine.drugmedia_commonJournal of Psychiatric Research
researchProduct

Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia

2022

The EU-GEI Project was funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI). The Brazilian study was funded by the Säo Paulo Research Foundation under grant number 2012/0417-0.

Emotions1ST-EPISODE SCHIZOPHRENIADEFICITSfacial affect recognition genetic liability first episode psychosisfirst episode psychosisSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansCLINICAL HIGH-RISKSettore MED/25 - PsichiatriaPsychiatric Status Rating ScalesDepressive Disorder MajorARCHITECTUREPERCEPTIONIDENTIFICATIONUNAFFECTED SIBLINGSBIPOLAR DISORDERFacial ExpressionINDIVIDUALSPsychiatry and Mental healthPsychotic Disordersfacial affect recognitionCase-Control StudiesRELIABILITYSchizophreniaFacial Recognitiongenetic liabilitySchizophrenia bulletin
researchProduct

Attentional processing biases to threat in schizophrenia: Evidence from a free-viewing task with emotional scenes

2021

Attentional biases to threatening stimuli have been suggested to play a key role in the onset and course of schizophrenia. However, current research has not completely demonstrated this assumption. The aim of this eye-tracking study was to shed light on the underlying psychological mechanisms of schizophrenia by examining the attentional processing of socio-emotional information. Forty-four individuals with schizophrenia and 47 healthy controls were assessed in a 3-s free-viewing task with a social scene (i.e., happy, threatening, or neutral) in competition with a non-social one to determine the effects of emotional information on the different stages of the attentional processing. The loca…

Eye MovementsSchizophrenia (object-oriented programming)EmotionsVulnerabilityEye movementAttentional biasGazeAttention Emotion Eye movements Eye tracking PsychopathologyAttentional BiasPsychiatry and Mental healthBiasSchizophreniaHumansEye trackingMechanisms of schizophreniaPsychologyBiological PsychiatryCognitive psychologyPsychopathologyJournal of Psychiatric Research
researchProduct

The copy number variant involving part of the α7 nicotinic receptor gene contains a polymorphic inversion.

2008

The alpha7 nicotinic acetylcholine receptor gene (CHRNA7) is located at 15q13-q14 in a region that is strongly linked to the P50 sensory gating deficit, an endophenotype of schizophrenia and bipolar disorder. Part of the gene is a copy number variant, due to a duplication of exons 5-10 and 3' sequence in CHRFAM7A, which is present in many but not all humans. Maps of this region show that the two genes are in opposite orientation in the individual mainly represented in the public access human DNA sequence database (Build 36), suggesting that an inversion had occurred since the duplication. We have used fluorescent in situ hybridization to investigate this putative inversion. Analysis of inte…

Genetic MarkersMaleLinkage disequilibriumBipolar DisorderPan troglodytesalpha7 Nicotinic Acetylcholine ReceptorReceptors NicotinicLinkage DisequilibriumExonGene duplicationGeneticsSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.AnimalsHumansCopy-number variationGeneSettore MED/25 - PsichiatriaGenetics (clinical)Sequence DeletionSegmental duplicationChromosomal inversionGeneticsChromosomes Human Pair 15Polymorphism GeneticBase SequencebiologyCHRNA7Chromosome Mappinginversion schizophrenia bipolar disorder 15q13–q14 CHRNA7 segmental duplicationChromosome InversionSchizophreniabiology.proteinFemale
researchProduct

Immagini mentali, creatività e schizofrenia.

2011

Imagery mind Creativity Schizophrenia.Settore VET/01 - Anatomia Degli Animali DomesticiSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice

2019

Abstract Objectives To identify the variables that are associated with persistence to Aripiprazole-Long Acting (A-LAI), in adult patients with schizophrenia. Methods Observational, retrospective, non-interventional study involving 261 patients with schizophrenia. Results Eighty-six percent of study subjects were persistent for at least 6 months. All subjects with baseline CGI-S of 1 or 2, 95% of subjects with CGI-S of 3, 86% with CGI-S of 4, 82% of subjects with CGI-S of 5, 73% of subjects with CGI of 6 and 90% of subjects with CGI of 7 were persistent. A-LAI treatment continuation rate was higher in patients with: 1) baseline CGI score ≤ 4; 2) schizophrenia dimension (LDPS) mania score ≤ 5…

Long actingMaleAdherence; Aripiprazole; Long acting; Maintena; Persistence; Personalized; Psychiatry and Mental Health; Biological PsychiatryAdherence; Aripiprazole; Long acting; Maintena; Persistence; Personalized; Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Italy; Male; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Treatment OutcomePersonalizedAripiprazole0302 clinical medicineRetrospective StudieDelayed-Action PreparationMaintenaMiddle AgedhumanitiesClinical PracticeTreatment OutcomeItalySchizophreniaPsychiatry and Mental HealthAripiprazoleFemaleBiological psychiatrymedicine.symptomManiaHumanmedicine.drugAntipsychotic AgentsAdultmedicine.medical_specialtyMedication AdherencePersistence03 medical and health scienceshealth services administrationInternal medicinemental disordersmedicineTreatment persistenceHumansBiological PsychiatryRetrospective Studiesbusiness.industryRetrospective cohort studymedicine.diseaseAdherence; Aripiprazole; Long acting; Maintena; Persistence; Personalized;030227 psychiatryAntipsychotic AgentLong actingAdherenceDelayed-Action PreparationsSchizophreniabusiness030217 neurology & neurosurgery
researchProduct

Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Ne…

2022

Introduction: Information on the off–label use of Long–Acting Injectable (LAI) antipsychotics in the real world is lacking. In this study, we aimed to identify the sociodemographic and clinical features of patients treated with on– vs off–label LAIs and predictors of off–label First– or Second–Generation Antipsychotic (FGA vs. SGA) LAI choice in everyday clinical practice. Method: In a naturalistic national cohort of 449 patients who initiated LAI treatment in the STAR Network Depot Study, two groups were identified based on off– or on–label prescriptions. A multivariate logistic regression analysis was used to test several clinically relevant variables and identify those associated with th…

Long-acting injectable antipsychoticCross-Sectional StudiesOff-labelPersonality disorderBipolar disorderDelayed-Action PreparationsSchizophreniaHumansBipolar disorder; Long-acting injectable antipsychotics; Off-label; Personality disorder; Schizophrenia; Cross-Sectional Studies; Delayed-Action Preparations; Humans; Off-Label Use; Antipsychotic Agents; SchizophreniaOff-Label UseSettore MED/25 - PsichiatriaLong-acting injectable antipsychoticsAntipsychotic Agents
researchProduct

Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries

2018

Background: People with schizophrenia engage in low levels of physical activity (PA). However, few large-scale studies have investigated the factors that may influence PA participation in individuals with psychosis and data from low- and middle-income countries (LMICs) is especially scarce. Thus, we investigated PA correlates in a large sample of people with a psychosis diagnosis across 47 LMICs. Methods: Cross-sectional data from the World Health Survey, restricting to those with a self-reported lifetime diagnosis of schizophrenia/psychotic disorder, was analyzed. PA was assessed by the International Physical Activity Questionnaire (IPAQ) and participants were dichotomized into those that …

MaleHealth BehaviorPsychological intervention*PsychosisGlobal Health0302 clinical medicine*Developing countries/dk/atira/pure/subjectarea/asjc/2800/2803Developing countrie*ExerciseMobilityPsychiatry/dk/atira/pure/subjectarea/asjc/2700/2738*Physical activityPsychiatry and Mental healthSchizophreniaPsychiatry and Mental HealthMarital statusAnxietyFemaleBiological psychiatrymedicine.symptomPsychologyPsychosismedicine.medical_specialtyDeveloping countries; Exercise; Mobility; Physical activity; Psychiatry; Psychosis; Schizophrenia; Psychiatry and Mental Health; Biological PsychiatryPsychosiDeveloping countries03 medical and health sciencesmedicineHumansPsychiatryExerciseBiological PsychiatryPhysical activity*SchizophreniaOdds ratiomedicine.diseasePsychosisHealth Surveys030227 psychiatryCross-Sectional StudiesPsychotic DisordersSocioeconomic FactorsSchizophrenia*Psychiatry*Mobility030217 neurology & neurosurgeryDemographyDiagnosis of schizophrenia
researchProduct

The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and me…

2016

Background Obstructive sleep apnea (OSA) is a health hazard since it is associated with neurocognitive dysfunction and cardio-metabolic diseases. The prevalence of OSA among people with serious mental illness (SMI) is unclear. Method We searched major electronic databases from inception till 06/2015. Articles were included that reported the prevalence of OSA determined by polysomnography (PSG) or an apnea-hypopnea index (AHI) >5 events/hr, in people with major depressive disorder (MDD), bipolar disorder (BD) or schizophrenia. A random effects meta-analysis calculating the pooled prevalence of OSA and meta-regression of potential moderators were performed. Results Twelve articles were inc…

MalePredictive Value of TestPolysomnographyBody Mass Index0302 clinical medicineRisk FactorsPrevalenceBipolar disorder; Major depressive disorder; Obstructive sleep apnea; Schizophrenia; Serious mental illness; Sleep; Psychiatry and Mental Health; Clinical PsychologySerious mental illneobstructive sleep apneabipolar disorderAged 80 and overSleep Apnea Obstructivemedicine.diagnostic_testMiddle AgedSerious mental illnessObstructive sleep apnea Sleep Serious mental illness Major depressive disorder Bipolar disorder SchizophreniaClinical PsychologySchizophreniaserious mental illnessPsychiatry and Mental HealthPredictive value of testsMeta-analysisMajor depressive disorderPsychologyHumanAdultmedicine.medical_specialtyBipolar disorderPolysomnographyMajor depressive disorder03 medical and health sciencesPredictive Value of TestsInternal medicinemental disordersmedicineHumansBipolar disordersleepAgedDepressive Disorder Majormajor depressive disorderRisk Factormedicine.diseaseObstructive sleep apnea030227 psychiatryrespiratory tract diseasesObstructive sleep apneaschizophreniaPhysical therapySchizophreniaSleepBody mass index030217 neurology & neurosurgery
researchProduct